webinar register page

Webinar banner
Webinar: The Challenges and Promise of Artificial Intelligence in Drug Development
REGISTER NOW: The rapidly advancing fields of artificial intelligence, machine learning, and computational analysis have expedited many facets of our lives. It’s imperative that we explore how these technologies will impact and advance oncology research, too.

This virtual event brings together leading experts in the field to discuss the promise and challenges of AI implementation in drug development, diagnosis and clinical trial design. Panelists will participate in a moderated panel discussion followed by a 30-minute Q&A from you, our audience.

We'll also look forward to continuing this important conversation at the 2023 CureSearch Summit next April. To learn more about the 2023 CureSearch Summit, contact Chris Riley, National Director of Corporate Healthcare Partnerships, at chris.riley@curesearch.org.

01:32:00

Webinar logo
* Required information
Loading

Speakers

Belle Taylor
Chemist and Communications Professional @SomX: The Healthtech Agency
A chemist by training, Belle has a First Class Chemistry MSci from UCL, where she also undertook her PhD. Belle has experience working across biotech, AI and academia, and is co-editor of the book 'Artificial Intelligence in Oncology Drug Discovery and Development'. Belle is also a communications professional currently working across the healthtech industry in her role at SomX: The Healthtech Agency. As a science communicator, Belle regularly speaks at and chairs events across the UK and is co-host of the science comedy show "Our Disgusting Planet".
Dr. Sam Volchenboum
Associate Chief Research Informatics Officer @The Division of Biological Sciences at the University of Chicago
Dr. Volchenboum is an associate professor of pediatrics and the associate chief research informatics officer for the Division of Biological Sciences at the University of Chicago. He is the Dean of MastersPrograms, and he designed and launched the UChicago Master’s in Biomedical Informatics. His clinical specialty is pediatric hematology / oncology, caring for kids with cancer and blood diseases. His research group includes the University of Chicago’s Pediatric Cancer Data Commons, a group dedicated to liberating and democratizing international data for pediatric malignancies. He is the director of the Informatics Core for the Clinical and Translational Science Award (CTSA), and he is director of the UChicago Clinical Informatics fellowship program.
Dr. Riaz Gillani
Pediatric Hematology and Oncology Instructor @The Boston Children’s/Dana-Farber Cancer Institute program
Dr. Gillani is a Pediatric Hematology/Oncology Instructor in the Boston Children’s/ Dana-Farber Cancer Institute program. Dr. Gillani’s research focuses on clinically-oriented computational genomics. He graduated Phi Beta Kappa and Magna Cum Laude from Brown University with an Sc.B. and received his MD from the Johns Hopkins University School of Medicine where he worked with Dr. Ben Ho Park, pursuing translational research in circulating tumor-DNA-based diagnostic testing using droplet digital PCR technology in breast cancer models. Subsequently, Dr. Gillani pursued his pediatric residency training in the Boston Children’s Residency Program and worked in the lab of Dr. Kimberly Stegmaier where he investigated therapeutic vulnerabilities in neuroblastoma. After completing the clinical training component of his pediatric hematology/ oncology fellowship, Dr. Gillani performed post-doctoral research in the lab of Dr. Eliezer Van Allen. Dr. Gillani now applies computational approaches to de
Dr. Aziz Nazha
Executive Director of Early Clinical Development @Incyte
Dr. Nazha is currently Executive Director of Early Clinical Development at Incyte. Prior to joining Incyte, Dr. Nazha was a Global Tech Business Development for Healthcare Solutions at Amazon Web Services. He was tasked in building innovative healthcare solutions using machine learning, AI, cloud computing and other digital services to accelerate the adaptation of digital technologies in Healthcare, Pharma and Life Science companies. Prior to joining Amazon, Dr. Nazha was the Director of the Cleveland Clinic Center for Clinical Artificial Intelligence and an Associate Medical Director at Enterprise Analytics. He was also an Assistant Professor of Medicine at Lerner College of Medicine/Case Western Reserve University and an Associate Staff at the Department of Hematology and Medical Oncology at Taussig Cancer Institute, Cleveland Clinic. Dr. Nazha is an international expert and a keynote speaker in the application of AI in healthcare as well as the application of novel digital tools suc
Craig Knox
Co-Founder and CTO @DrugBank
Craig Knox draws on his more than 17 years of experience in computer science, genetics, and metabolomics and bioinformatics research to guide DrugBank’s rapid growth. For a decade, Craig served as a bioinformatician and team lead at the University of Alberta’s Genome Canada Research Helpdesk. He then went on to work as a software engineer at Xfire in Santa Monica before co-founding a global bioinformatics company focused on integrating AI tools with lab information management systems. Today, as co-founder and CTO of DrugBank, Craig leads an impressive team of software engineers, machine learning experts, data scientists, and curators, focusing on technology strategy and alignment, AI applications, and data integration and quality.